Good News in War Against COVID-19
Promising Oxford University Vaccine Source: Gilead Sciences Successful Gilead Sciences Treatment In the war against COVID-19, some good news. Gilead Sciences' remdesivir has shown improvement in patients taking it to treat the virus. That, according to Gilead's own study. On top of that, testing by the National Institution of Allergy and Infectious Disease also gave the drug "positive data" results in their own testing. This news raised hopes on Wall Street that a treatment/cure is near and that the economy may be able to open safely again. At the start of trading, the DJIA shot up 400 points and Gilead shares were up 9.3%. Promising Vaccine Meanwhile, researchers at Oxford University in the UK say they could have a COVID-19 vaccine ready for humans by the 4th quarter of this year. Their experimental vaccine has proven effective in protecting monkeys from the virus. Monkeys ...